Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal Function

NCT03896750 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Renal Impairment
Tuberculosis

Interventions

DRUG: PA-824

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)